M
TARO

Murchinson’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Murchinson’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-54,137
Closed -$2.29M – 113
2024
Q1 		$2.29M Sell
54,137
-113,645
-68% -$4.79M 0.19% 50
2023
Q4 		$7.01M Buy
167,782
+64,038
+62% +$2.36M 1.22% 12
2023
Q3 		$3.91M Hold
103,744
– – 0.5% 24
2023
Q2 		$6.61M Sell
103,744
-2,170
-2% -$68.1K 0.84% 10
2023
Q1 		$2.58M Hold
105,914
– – 0.37% 20
2022
Q4 		$3.08M Sell
105,914
-69,606
-40% -$2.06M 0.41% 14
2022
Q3 		$5.26M Buy
175,520
+2,000
+1% +$69K 1.52% 14
2022
Q2 		$6.27M Buy
173,520
+10,817
+7% +$412K 1.2% 9
2022
Q1 		$7.04M Buy
162,703
+3,500
+2% +$164K 1.34% 11
2021
Q4 		$7.98M Buy
159,203
+59,203
+59% +$3.32M 0.76% 15
2021
Q3 		$6.36M Hold
100,000
– – 3.16% 9
2021
Q2 		$7.2M Buy
+100,000
New +$7.35M 2.59% 8

Other funds holding TARO

KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Murchinson's TARO Position: Q2 2024 in Review

Murchinson sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 54,137 shares — an estimated $2.29M sold.

Murchinson first reported a position in TARO in Q2 2021 and held it in 12 quarters. The position peaked at $7.98M in Q4 2021. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Murchinson reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Murchinson sold 54,137 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $2.29M.
  • Murchinson first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2021 and held it in 12 quarters.
  • Murchinson's Taro Pharmaceutical Industries Ltd. position peaked at $7.98M in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Murchinson's 13F filing for Q2 2024, filed 14 Aug 2024.